Cargando…
CYP2D6 GENOTYPE AND REDUCED CODEINE ANALGESIC EFFECT IN REAL-WORLD CLINICAL PRACTICE
Cytochrome P450 2D6 (CYP2D6) O-demethylates codeine to the active drug, morphine. However, the utility of testing for CYP2D6 metabolizer status in patients receiving codeine in real-world clinical practice is poorly defined. Using data from a DNA bank linked to de-identified electronic health record...
Autores principales: | Carranza-Leon, Daniel, Dickson, Alyson L., Gaedigk, Andrea, Stein, C. Michael, Chung, Cecilia P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295171/ https://www.ncbi.nlm.nih.gov/pubmed/33750887 http://dx.doi.org/10.1038/s41397-021-00226-8 |
Ejemplares similares
-
Prediction of CYP2D6 phenotype from genotype across world populations
por: Gaedigk, Andrea, et al.
Publicado: (2017) -
Effect of codeine on CYP450 isoform activity of rats
por: Wang, Shuanghu, et al.
Publicado: (2017) -
Functional phenotyping of the CYP2D6 probe drug codeine in the horse
por: Gretler, S. R., et al.
Publicado: (2021) -
How Resistant to Tampering are Codeine Containing Analgesics on the Market? Assessing the Potential for Opioid Extraction
por: Kimergård, Andreas, et al.
Publicado: (2016) -
Codeine in Diabetes
Publicado: (1890)